nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Autoimmunity and Novel Therapies in Immune-Mediated Thrombocytopenia
|
Yehudai, Dana |
|
2013 |
50 |
S1 |
p. S100-S108 9 p. |
artikel |
2 |
B-Cell Depletion in Immune Thrombocytopenia
|
Godeau, Bertrand |
|
2013 |
50 |
S1 |
p. S75-S82 8 p. |
artikel |
3 |
CD4+CD25+Foxp3+ Regulatory T Cells in the Pathophysiology of Immune Thrombocytopenia
|
Nishimoto, Tetsuya |
|
2013 |
50 |
S1 |
p. S43-S49 7 p. |
artikel |
4 |
Cell Death in Immune Thrombocytopenia: Novel Insights and Perspectives
|
von Gunten, Stephan |
|
2013 |
50 |
S1 |
p. S109-S115 7 p. |
artikel |
5 |
Childhood Immune Thrombocytopenia—Who Will Spontaneously Recover?
|
Yacobovich, Joanne |
|
2013 |
50 |
S1 |
p. S71-S74 4 p. |
artikel |
6 |
Chronic Immune Thrombocytopenia in Children: Who Needs Splenectomy?
|
Schifferli, Alexandra |
|
2013 |
50 |
S1 |
p. S58-S62 5 p. |
artikel |
7 |
Commentary on Session: Immune Thrombocytopenia Nomenclature, Guidelines, and Natural History
|
Bolton-Maggs, Paula H.B. |
|
2013 |
50 |
S1 |
p. S10-S11 2 p. |
artikel |
8 |
DNA Methylation and Primary Immune Thrombocytopenia
|
Li, Huiyuan |
|
2013 |
50 |
S1 |
p. S116-S126 11 p. |
artikel |
9 |
Immune Dysregulation in Immune Thrombocytopenia
|
Yazdanbakhsh, Karina |
|
2013 |
50 |
S1 |
p. S63-S67 5 p. |
artikel |
10 |
Immune Thrombocytopenia and B-Cell-Activating Factor/A Proliferation-Inducing Ligand
|
Liu, Xin-guang |
|
2013 |
50 |
S1 |
p. S89-S99 11 p. |
artikel |
11 |
Immune Thrombocytopenia Nomenclature, Consensus Reports, and Guidelines: What Are the Consequences for Daily Practice and Clinical Research?
|
Michel, Marc |
|
2013 |
50 |
S1 |
p. S50-S54 5 p. |
artikel |
12 |
Immune Thrombocytopenia Patients Requiring Anticoagulation—Maneuvering Between Scylla and Charybdis
|
Matzdorff, Axel |
|
2013 |
50 |
S1 |
p. S83-S88 6 p. |
artikel |
13 |
Individualized Treatment for Immune Thrombocytopenia: Predicting Bleeding Risk
|
Neunert, Cindy E. |
|
2013 |
50 |
S1 |
p. S55-S57 3 p. |
artikel |
14 |
Innate and Adaptive Immunity in Immune Thrombocytopenia
|
Lazarus, Alan H. |
|
2013 |
50 |
S1 |
p. S68-S70 3 p. |
artikel |
15 |
Occult Hemorrhage in Immune Thrombocytopenia
|
Flores, Adolfo |
|
2013 |
50 |
S1 |
p. S26-S30 5 p. |
artikel |
16 |
outside front cover, PMS 8883 metallic AND 4/C
|
|
|
2013 |
50 |
S1 |
p. OFC- 1 p. |
artikel |
17 |
Selected Topics of the 4th International Cooperative Study Group Meeting on Immune Thrombocytopenia Revisited
|
Nydegger, Urs E. |
|
2013 |
50 |
S1 |
p. S3-S9 7 p. |
artikel |
18 |
Standardized Clinical Assessment and Management Plans (SCAMPs): Perspectives on a New Method to Understand Treatment Decisions and Outcomes in Immune Thrombocytopenia
|
Grace, Rachael F. |
|
2013 |
50 |
S1 |
p. S31-S38 8 p. |
artikel |
19 |
Supplement Sponsorship
|
|
|
2013 |
50 |
S1 |
p. IFC- 1 p. |
artikel |
20 |
suppl masthead
|
|
|
2013 |
50 |
S1 |
p. A1- 1 p. |
artikel |
21 |
suppl TOC
|
|
|
2013 |
50 |
S1 |
p. A2-A3 nvt p. |
artikel |
22 |
4th Intercontinental Cooperative ITP Study Group (ICIS) Expert Meeting in Montreux, Switzerland, September 2012
|
Kühne, Thomas |
|
2013 |
50 |
S1 |
p. S1-S2 2 p. |
artikel |
23 |
Three Decades of Experience in Managing Immune Thrombocytopenia in Children in Arab Countries
|
Elalfy, Mohsen Saleh |
|
2013 |
50 |
S1 |
p. S22-S25 4 p. |
artikel |
24 |
Thrombopoietin Receptor Agonists in Primary Immune Thrombocytopenia
|
Siegal, Deborah |
|
2013 |
50 |
S1 |
p. S18-S21 4 p. |
artikel |
25 |
To Treat or Not To Treat—From Guidelines to Individualized Patient Management
|
Matzdorff, Axel |
|
2013 |
50 |
S1 |
p. S12-S17 6 p. |
artikel |
26 |
Understanding the Importance of Using Patient-Reported Outcome Measures in Patients With Immune Thrombocytopenia
|
Kirsch, Monika |
|
2013 |
50 |
S1 |
p. S39-S42 4 p. |
artikel |